SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending amid community excitement around upcoming airdrops and continued token burns, designed to reward holders. Community members, or 'Brokies', are touting its strong community and steady growth on the Solana blockchain. The project's focus on community-driven growth and upcoming utilities are also key talking points.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood (HOOD) is trending after announcing its inclusion in the S&P 500, driving significant discussion about its growth as a platform and potential for further expansion. The community is buzzing about the stock's potential and the upcoming product summit. Some are speculating on new features and banking services, while others are debating the stock's valuation and possible short-term pullbacks.

Asset Entities, Inc. engages in providing social media marketing and content delivery services. It offers its services to Discord, TikTok, and other social media platforms. It also designs, develops and manages servers for communities on Discord. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani and Kyle Fairbanks on August 1, 2020 and is headquartered in Dallas, TX.

Asset Entities Inc - Ordinary Shares - Class B

Asset Entities Inc.

Asset Entities Inc. ($ASST) is trending due to its upcoming merger with Strive Enterprises and potential for a Bitcoin treasury, sparking comparisons to other high-flying crypto plays. The community is focused on a potential short squeeze, citing high short interest and cost to borrow, with some anticipating a significant price increase. Discussions also involve the involvement of prominent investors and the potential impact of the merger on the company's valuation and treasury strategy.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending after hours due to news of a special warrant dividend, offering shareholders the option to purchase additional shares at $32, and a positive earnings report. The community is buzzing about the potential implications for short sellers, speculating on a possible squeeze as shorts may need to acquire warrants to cover their positions. Broader discussions include the company's cash position and future strategies.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is gaining traction amid discussions around corporate treasury initiatives and a potential surge in DeFi activity. The community highlights upcoming developments around memecoins built on Solana, specifically around airdrops and community burns. Broader market analysis suggests increased institutional interest and potential for Solana to outperform other major cryptocurrencies.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle's stock is surging following reports of substantial cloud infrastructure growth and a massive increase in remaining performance obligations driven by large AI contracts, despite mixed earnings. The community is buzzing about the company's future revenue potential and multi-billion dollar deals, with some questioning the aggressive growth forecasts, while others view it as a long-term AI play.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple's stock is trending amidst discussions around its latest product announcements, including the iPhone Air, with community chatter focusing on design choices and the absence of significant AI advancements. While some express disappointment, others predict strong sales, particularly for the new iPhone Air, citing its sleek design. The broader context involves debates about Apple's innovation pipeline and its competitive positioning in the AI landscape.

Armada Acquisition Corp. I operates as a blank check company. It was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was founded on November 5, 2020 and is headquartered in Philadelphia, PA.

Rezolve AI PLC .

Rezolve AI Limited

Rezolve AI (RZLV) is trending as investors discuss institutional buying and potential buyouts from major tech companies, fueling optimism. Community members are highlighting the company's fundamentals, partnerships with Microsoft and Google, and the upcoming earnings report. There's also discussion around a General Meeting of Shareholders set for September 30, 2025, that will address the company's adoption of the annual accounts and Director's Report for 2024.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG.X is trending as community members highlight its strong connection to Bitcoin, being built on the Runes protocol, and its fair launch with no insiders or VC allocation, sparking discussions about its potential to disrupt the meme coin landscape. The community emphasizes that $DOG.X secures the Bitcoin network through transaction fees and promotes a culture-driven movement, leading to accumulation.

ONDO is a DeFi primitive that enables users to originate risk-isolated, fixed yield loans backed by yield-generating crypto-assets. It's unique because it's a permissionless protocol that allows users to interact on a peer-to-pool basis with no intermediaries.

Ondo

ONDO is trending as investors discuss its potential in the Real World Asset (RWA) tokenization space, particularly following news around traditional finance integrating with blockchain. Community members are weighing the potential impact of tokenizing assets and broader adoption of RWAs. Some are also looking to potential short-term price movements.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here's What Key Metrics Tell Us About Royalty Pharma (RPRX) Q2 Earnings

The headline numbers for Royalty Pharma (RPRX) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Royalty Pharma (RPRX) Tops Q2 Earnings and Revenue Estimates

Royalty Pharma (RPRX) delivered earnings and revenue surprises of +3.64% and +5.94%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Countdown to Royalty Pharma (RPRX) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS

Evaluate the expected performance of Royalty Pharma (RPRX) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Royalty Pharma (RPRX) Earnings Expected to Grow: Should You Buy?

Royalty Pharma (RPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?

Royalty Pharma Plc. (RPRX) on Tuesday announced a $2 billion funding arrangement with Revolution Medicines (RVMD), aimed at supporting the latter’s plans for global development of its investigational cancer drug Daraxonrasib.As per the <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.revmed.com/news-releases/news-release-details/revolution-medicines-enters-2-billion-flexible-funding-agreement">arrangement</a>, Royalty Pharma will provide up to $1.25 billion to Revolution Medicines in exchange for a synthetic royalty on annual worldwide net sales of Daraxonrasib for a term of 15 years and a senior secured loan of up to $750 million.Synthetic royalty financing is a type of funding where a company sells a portion of its future revenue stream in exchange for upfront capital, without relinquishing ownership of the underlying asset.Funds worth $1.25 billion will be awarded in five tranches upon Revolution Medicines hitting certain product development milestones. The first two $250 million tranches, totaling $500 million, are payable prior to the FDA’s approval of Daraxonrasib, and royalty obligations begin only after that.The funds, Royalty Pharma said, will support Revolution Medicines’ plans for global development and commercialization of Daraxonrasib and its pipeline programs for patients with RAS-addicted cancers.Daraxonrasib is an experimental drug in late-stage development for RAS mutant pancreatic cancer and non-small cell lung cancer (NSCLC). RAS is one of the most commonly mutated genes in human cancer, and the drug works by targeting RAS proteins.In the U.S., approximately 56,000 patients are diagnosed with RAS-driven pancreatic cancer annually, while approximately 60,000 patients are diagnosed with RAS-driven NSCLC annually, Royalty Pharma said.Revolution Medicines expects late-stage trial results for Daraxonrasib in pancreatic cancer in 2026.Revolution Medicines CEO Mark A. Goldsmith said that the funding agreement “significantly increases” the financial resources the company can deploy.The company had cash, cash equivalents, and marketable securities of $2.1 billion as of March 31. The company said on Tuesday that it is removing its cash runway end date guidance owing to the new funding agreement.On Stocktwits, retail sentiment around RVMD fell from ‘bullish’ to ‘neutral’ territory over the past 24 hours while message volume increased from ‘low’ to ‘high’ levels.<figure class="image"><img style="aspect-ratio:626/64;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_24_at_9_43_59_AM_png_4b2fb6ec49.webp" alt="RVMD's Sentiment Meter and Message Volume as of 9:40 a.m. ET on June 24, 2025 | Source: Stocktwits" width="626" height="64"><figcaption>RVMD's Sentiment Meter and Message Volume as of 9:40 a.m. ET on June 24, 2025 | Source: Stocktwits</figcaption></figure>As for RPRX, retail sentiment stayed unmoved within ‘bearish’ territory over the past 24 hours while message volume improved from ‘low’ to ‘normal’ levels.<figure class="image"><img style="aspect-ratio:631/66;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_24_at_9_45_20_AM_png_2660096f57.webp" alt="RPRX's Sentiment Meter and Message Volume as of 9:45 a.m. ET on June 24, 2025 | Source: Stocktwits" width="631" height="66"><figcaption>RPRX's Sentiment Meter and Message Volume as of 9:45 a.m. ET on June 24, 2025 | Source: Stocktwits</figcaption></figure> RVMD is trading nearly 2% lower on Tuesday morning.While <a href="https://stocktwits.com/symbol/RVMD">RVMD stock</a> is down by about 10% this year, <a href="https://stocktwits.com/symbol/RPRX">RPRX</a> is up by about 41%.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/verizon-ai-powered-overhaul-of-customer-support-draws-retail-praise/chm49CNRR34">Verizon’s AI-Powered Overhaul Of Customer Support Draws Retail Praise</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Revolution Medicines company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

Revolution Medicines To Get Up To $2B For Development Of Cancer Drug From Royalty Pharma

Royalty Pharma will provide up to $1.25 billion to Revolution Medicines in exchange for a synthetic royalty on annual worldwide net sales of Daraxonrasib for a term of 15 years and a senior secured loan of up to $750 million.

Equity

2 Hot Growth Stocks Poised for Gains of Up to 370%, According to Wall Street

These biotech companies’ strategic advancements are setting them up for long-term success.

2  ‘Strong Buy’ Growth Stocks Poised for 141% to 193% Gains, According to Wall Street

The recent advancements in their pipelines imply high growth potential in the coming years.

Insights Ahead: Royalty Pharma's Quarterly Earnings

Syndax Pharmaceuticals and Royalty Pharma Enter into $350 Million Royalty Funding Agreement for Niktimvo

Syndax Pharmaceuticals and Royalty Pharma Enter into $350 Million Royalty Funding Agreement for Niktimvo Syndax Pharmaceuticals and Royalty Pharma Enter into $350 Million Royalty Funding Agreement...

Royalty Pharma Plc engages in the provision of drug development services. It operates as a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio includes royalties, including AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko and Trikafta, and five development-stage product candidates. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY.

Current Price	$36.50
Prev Close	$35.80
Open	$35.77
Dividend Yield	3.29%
50-Day Moving Average	$36.33
Beta	0.39
Avg. Volume	3.14M
PE Ratio	15.59

52-Week High	$38.00
52-Week Low	$24.05
Market Capitalization	$15.48B
EPS (Annual)	$1.91
Price to Book	2.44
Revenue Per Employee	$22.86M
Enterprise Value/EBITDA	N/A

RPRX
Royalty Pharma plc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RPRX News

RPRX Royalty Pharma plc - Ordinary Shares - Class A